MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q1 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $303,327 | -25.7% | 11,251 | -50.4% | 0.16% | -3.1% |
| Q3 2022 | $408,000 | +46.8% | 22,690 | +1.5% | 0.16% | +58.3% |
| Q2 2022 | $278,000 | +95.8% | 22,356 | +109.8% | 0.10% | +60.9% |
| Q1 2022 | $142,000 | -19.3% | 10,655 | -5.6% | 0.06% | -3.0% |
| Q4 2021 | $176,000 | -19.6% | 11,289 | +15.7% | 0.07% | -31.2% |
| Q3 2021 | $219,000 | -6.4% | 9,755 | -5.0% | 0.10% | 0.0% |
| Q2 2021 | $234,000 | -8.6% | 10,270 | -17.6% | 0.10% | -11.1% |
| Q1 2021 | $256,000 | -24.3% | 12,457 | +1.8% | 0.11% | -22.9% |
| Q4 2020 | $338,000 | +31.5% | 12,236 | -33.2% | 0.14% | +3.7% |
| Q3 2020 | $257,000 | -40.1% | 18,324 | -12.0% | 0.14% | -33.5% |
| Q2 2020 | $429,000 | +138.3% | 20,817 | -12.9% | 0.20% | +174.3% |
| Q1 2020 | $180,000 | -57.6% | 23,895 | -12.7% | 0.07% | +7.2% |
| Q4 2019 | $425,000 | +179.6% | 27,369 | -6.2% | 0.07% | +122.6% |
| Q3 2019 | $152,000 | -45.5% | 29,180 | -5.3% | 0.03% | -47.5% |
| Q2 2019 | $279,000 | – | 30,799 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |